| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.28 | 9e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |